RGBO Insider Trading Activity and SEC Form 4 Filings
RGBO insider trading summary
No open-market insider purchases or sales of Regen Biologics Inc (RGBO) have been reported on SEC Form 4 in the past 12 months.
Latest RGBO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 14, 2009 | Robert G McNeil | Director | Buy | $15K (5,000 @ $2.95) |
| Apr 13, 2009 | Robert G McNeil | Director | Buy | $15K (5,000 @ $2.96) |
| Apr 3, 2009 | Robert G McNeil | Director | Buy | $15K (5,000 @ $2.92) |
| Apr 2, 2009 | Robert G McNeil | Director | Buy | $15K (5,000 @ $2.90) |
| Apr 1, 2009 | Robert G McNeil | Director | Buy | $750 (300 @ $2.50) |
| Feb 19, 2009 | Gerald Bisbee JR | Chairman, President & CEO | Buy | $3K (1,000 @ $2.60) |
| Feb 19, 2009 | Gerald Bisbee JR | Chairman, President & CEO | Buy | $3K (1,000 @ $2.50) |
| Feb 13, 2009 | William Rodkey | Vice President | Buy | $5K (1,429 @ $3.50) |
| Feb 13, 2009 | Alan W Baldwin | Director | Buy | $10K (2,854 @ $3.50) |
| Jan 16, 2009 | Brion Umidi | Sr. Vice President & CFO | Buy | $12K (3,376 @ $3.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.